Central Nervous System Agents in Medicinal Chemistry, 23 (2), 137143
Liposomal delivery ensures that the nutrient is protected and delivered directly where it can be most effective.
That opportunity is now supported by manufacturing commitments, including Novo Nordisk's March 2026 announcement of a EUR 432 million expansion in Athlone, Ireland, to increase capacity for oral GLP-1 therapies, alongside Eli Lilly's November 2025 plan to build a USD 3 billion manufacturing facility in Katwijk, the Netherlands, aimed at oral medicines including the GLP-1 receptor agonist orforglipron
Medvi: GLP-1 dosing and administration Getting a prescription is only part of the process
Insurance coverage for liraglutide and semaglutide varies significantly depending on your insurance plan and the health condition being treated
PubMed, Zhou, Dongchen, et al